Nassir Ghaemi, MD MPH

Nassir Ghaemi MD MPH is a psychiatrist and researcher with expertise in depression and bipolar illness, and training in philosophy and public health. He is Lecturer on Psychiatry at Harvard Medical School (Cambridge Health Alliance) and Professor of Psychiatry at Tufts University (Tufts Medical Center). He also previously directed early drug discovery at Novartis Institutes for Biomedical Research in Cambridge MA. He is the author of multiple books, most recently Clinical Psychopharmacology (Oxford University Press, 2019), and also including the New York Times Bestseller, A First-Rate Madness (Penguin, 2011). He has published over 300 scientific articles or book chapters. He is an associate editor of Acta Psychiatrica Scandinavica, on the editorial board of a number of journals, and active in numerous professional organizations.
Dr. Ghaemi has a medical degree from the Medical College of Virginia in Richmond, completed medical and psychiatry residency training at Harvard in the Massachusetts General Hospital and McLean Hospital programs, received a Master of Arts degree in philosophy from Tufts University, and a Master of Public Health degree from the Harvard School of Public Health.
Financial relationships
-
Attribution:SelfType of financial relationship:EmploymentIneligible company:NovartisTopic:Drug discoveryDate added:01/30/2023Date updated:01/30/2023Relationship end date:06/01/2021
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward